HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary of
— Fruquintinib treatment reduced the risk of death by 34% in metastatic colorectal cancer (0.66 HR) — — Increased disease control with risk of disease...
Source: globenewswire.com
Page 8 - Stat Facts News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stat Facts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stat Facts Today - Breaking & Trending Today
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
/PRNewswire/ -- Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment...
Source: prnewswire.com
HUTCHMED Highlights Fruquintinib MRCT FRESCO-2 Data to be Presented at the Upcoming ESMO Congress 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
/PRNewswire/ -- Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced...
Source: prnewswire.com
Daiichi Sankyo: DS-6000 Suggests Early Clinical Activity in Patients with Advanced Ovarian Cancer or Renal Cell Carcinoma
Initial dose escalation results from first-in-human phase 1 trial of DS-6000, Daiichi Sankyo's fifth DXd ADC in clinical development, featured in oral presentation at ASCO Dose expansion phase
Source: finanznachrichten.de